Melanin concentrating hormone receptor ligands (especially substituted tetrahydroisoquinoline analogues), capable of modulating MCH receptor activity, are provided. Such ligands may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).
提供了
黑色素浓集激素受体
配体(特别是取代的
四氢异喹啉类似物),能够调节MCH受体活性。这些
配体可用于体内或体外调节MCH结合到MCH受体,并在人类、家畜伴侣动物和牲畜动物的各种代谢、进食和性功能障碍治疗中特别有用。提供了用于治疗此类疾病的药物组合物和方法,以及用于检测MCH受体的方法(例如受体定位研究)。